Revelation Biosciences Inc (REVB) has fallen Friday morning, with the stock declining -7.03% in pre-market trading to 1.19. REVB's short-term technical score of 23 indicates that the stock has traded less bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, the stock ranks higher than 41% of stocks. Revelation Biosciences Inc has fallen 21.47% over the past month, closing at $2.58 on March 25. During this period of time, the stock fell as low as $0.75 and as high as $2.88. REVB has an average analyst recommendation of Strong Buy. The company has an average price target of $9.00.
REVB has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on REVB!